Brief: SMS Pharmaceuticals Gets EIR From U.S. FDA for Manufacturing Facility in Hyderabad

SMS Pharmaceuticals

22/01/2018 09:02

Jan 22 (Reuters) - Sms Pharmaceuticals Ltd  SMSP.NS : 
    * GETS ESTABLISHMENT INSPECTION REPORT(EIR) FROM US FDA 
    * SAYS THERE WERE NO FORM 483 OBSERVATIONS DURING OF 
FACILITY IN 
HYDERABAD 
 
Source text - http://bit.ly/2BjYi32 
Further company coverage:  SMSP.NS  
 
 ((Bangalore.newsroom@thomsonreuters.com;))